- Home
- SOPH vs OPRX Comparison
SOPH vs OPRX Comparison
Compare SOPH & OPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- OPRX
- Stock Information
- Founded
- SOPH 2011
- OPRX 2006
- Country
- SOPH Switzerland
- OPRX United States
- Employees
- SOPH N/A
- OPRX N/A
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- OPRX Business Services
- Sector
- SOPH Health Care
- OPRX Consumer Discretionary
- Exchange
- SOPH Nasdaq
- OPRX Nasdaq
- Market Cap
- SOPH 231.8M
- OPRX 234.9M
- IPO Year
- SOPH 2021
- OPRX N/A
- Fundamental
- Price
- SOPH $3.18
- OPRX $18.92
- Analyst Decision
- SOPH
- OPRX Buy
- Analyst Count
- SOPH 0
- OPRX 8
- Target Price
- SOPH N/A
- OPRX $11.81
- AVG Volume (30 Days)
- SOPH 36.6K
- OPRX 354.6K
- Earning Date
- SOPH 11-04-2025
- OPRX 11-12-2025
- Dividend Yield
- SOPH N/A
- OPRX N/A
- EPS Growth
- SOPH N/A
- OPRX N/A
- EPS
- SOPH N/A
- OPRX N/A
- Revenue
- SOPH $69,688,000.00
- OPRX $104,748,000.00
- Revenue This Year
- SOPH $16.60
- OPRX $17.92
- Revenue Next Year
- SOPH $18.77
- OPRX $10.91
- P/E Ratio
- SOPH N/A
- OPRX N/A
- Revenue Growth
- SOPH 7.32
- OPRX 25.89
- 52 Week Low
- SOPH $2.58
- OPRX $3.78
- 52 Week High
- SOPH $4.92
- OPRX $19.25
- Technical
- Relative Strength Index (RSI)
- SOPH 44.52
- OPRX 60.17
- Support Level
- SOPH $3.10
- OPRX $17.07
- Resistance Level
- SOPH $3.49
- OPRX $18.85
- Average True Range (ATR)
- SOPH 0.16
- OPRX 1.07
- MACD
- SOPH -0.02
- OPRX -0.10
- Stochastic Oscillator
- SOPH 19.51
- OPRX 87.06
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About OPRX OptimizeRx Corporation
OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.